You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus

Article info

Article menu
Epidemiology and outcomes
Original research
Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus

Authors

  • Eleana Bolla First Department of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Nikolas Tentolouris First Department of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Petros P Sfikakis First Department of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  • Maria G Tektonidou First Department of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  1. Correspondence to Prof Maria G Tektonidou; mtektonidou{at}gmail.com
View Full Text

Citation

Bolla E, Tentolouris N, Sfikakis PP, et al
Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus
Lupus Science & Medicine 2021;8:e000579. doi: 10.1136/lupus-2021-000579

Publication history

  • Received September 12, 2021
  • Accepted November 30, 2021
  • First published December 17, 2021.
Online issue publication 
December 17, 2021

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.